Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03161756 |
| Title | Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma (CHARLI) |
| Acronym | CHARLI |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Melanoma and Skin Cancer Trials Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |